Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-025405
Filing Date
2015-04-28
Accepted
2015-04-28 08:00:25
Documents
9
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F v407920_20f.htm 20-F 2032741
2 EXHIBIT 21.1 v407920_ex21-1.htm EX-21.1 3446
3 EXHIBIT 23.1 v407920_ex23-1.htm EX-23.1 2683
4 EXHIBIT 23.2 v407920_ex23-2.htm EX-23.2 2551
5 EXHIBIT 23.3 v407920_ex23-3.htm EX-23.3 3019
6 EXHIBIT 31.1 v407920_ex31-1.htm EX-31.1 9717
7 EXHIBIT 31.2 v407920_ex31-2.htm EX-31.2 9736
8 EXHIBIT 32.1 v407920_ex32-1.htm EX-32.1 5071
9 GRAPHIC tlogo.jpg GRAPHIC 4349
  Complete submission text file 0001144204-15-025405.txt   2076106
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 20-F | Act: 34 | File No.: 001-36000 | Film No.: 15796656
SIC: 2834 Pharmaceutical Preparations